[go: up one dir, main page]

NO20013118L - Anvendelse av en 5HT2A og 5HT2A/C reseptor-antagonist for fremstilling av medisiner for behandling av snorking og syndrommed höy motstand i övre anatomiske luftveier - Google Patents

Anvendelse av en 5HT2A og 5HT2A/C reseptor-antagonist for fremstilling av medisiner for behandling av snorking og syndrommed höy motstand i övre anatomiske luftveier

Info

Publication number
NO20013118L
NO20013118L NO20013118A NO20013118A NO20013118L NO 20013118 L NO20013118 L NO 20013118L NO 20013118 A NO20013118 A NO 20013118A NO 20013118 A NO20013118 A NO 20013118A NO 20013118 L NO20013118 L NO 20013118L
Authority
NO
Norway
Prior art keywords
5ht2a
snoring
treatment
high resistance
airways
Prior art date
Application number
NO20013118A
Other languages
English (en)
Other versions
NO20013118D0 (no
Inventor
Francoise Cattelin
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20013118D0 publication Critical patent/NO20013118D0/no
Publication of NO20013118L publication Critical patent/NO20013118L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
NO20013118A 1998-12-22 2001-06-21 Anvendelse av en 5HT2A og 5HT2A/C reseptor-antagonist for fremstilling av medisiner for behandling av snorking og syndrommed höy motstand i övre anatomiske luftveier NO20013118L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9816295A FR2787328A1 (fr) 1998-12-22 1998-12-22 Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
PCT/FR1999/003122 WO2000037068A1 (fr) 1998-12-22 1999-12-14 Utilisation d'un antagoniste des recepteurs 5ht2a, et 5ht2a/c pour la preparation de medicaments destines au traitement des ronflements et du syndrome de haute resistance des voies aeriennes superieures

Publications (2)

Publication Number Publication Date
NO20013118D0 NO20013118D0 (no) 2001-06-21
NO20013118L true NO20013118L (no) 2001-07-23

Family

ID=9534374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013118A NO20013118L (no) 1998-12-22 2001-06-21 Anvendelse av en 5HT2A og 5HT2A/C reseptor-antagonist for fremstilling av medisiner for behandling av snorking og syndrommed höy motstand i övre anatomiske luftveier

Country Status (15)

Country Link
US (1) US6576670B1 (no)
EP (1) EP1140055B1 (no)
JP (1) JP2002532548A (no)
KR (1) KR20010086459A (no)
CN (1) CN1331588A (no)
AT (1) ATE236625T1 (no)
AU (1) AU1570200A (no)
BR (1) BR9916434A (no)
CA (1) CA2351674A1 (no)
DE (1) DE69906795D1 (no)
FR (1) FR2787328A1 (no)
IL (1) IL143143A0 (no)
NO (1) NO20013118L (no)
WO (1) WO2000037068A1 (no)
ZA (1) ZA200104399B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060069124A1 (en) * 2004-09-07 2006-03-30 Rao P S Use of MDL-100,907 for treatment of allergic and eosinophil mediated diseases
EP2255807A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Method of treating sleep disorders using the combination of eplivanserin and zolpidem
EP2269600A1 (en) * 2009-07-02 2011-01-05 Sanofi-Aventis Treatment of sleep disorders using eplivanserin in COPD patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639942B1 (fr) 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
ATE114467T1 (de) 1990-06-01 1994-12-15 Merrell Dow Pharma (+)-alpha-(2,3 dimethoxyphenyl)-1-(2- (fluorophenyl)ethyl>-4-piperidinmethanol.
DE19707628A1 (de) * 1997-02-26 1998-08-27 Merck Patent Gmbh Oxazolidinone
US5844000A (en) * 1997-06-12 1998-12-01 Sanofi Propenone oxime ethers and pharmaceutical compositions containing them
FR2765107B1 (fr) * 1997-06-26 2000-03-24 Sanofi Sa Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
ATE324110T1 (de) * 1998-02-27 2006-05-15 Univ Illinois Stoffe mit serotoninartiger wirkung zur behandlung der schlafapnoe
US6277864B1 (en) * 1998-08-28 2001-08-21 Aventis Pharmaceuticals Inc. Use of R- +)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders

Also Published As

Publication number Publication date
CA2351674A1 (en) 2000-06-29
DE69906795D1 (de) 2003-05-15
ZA200104399B (en) 2002-05-02
FR2787328A1 (fr) 2000-06-23
EP1140055B1 (fr) 2003-04-09
WO2000037068A1 (fr) 2000-06-29
US6576670B1 (en) 2003-06-10
JP2002532548A (ja) 2002-10-02
IL143143A0 (en) 2002-04-21
CN1331588A (zh) 2002-01-16
NO20013118D0 (no) 2001-06-21
WO2000037068B1 (fr) 2000-09-14
KR20010086459A (ko) 2001-09-12
ATE236625T1 (de) 2003-04-15
EP1140055A1 (fr) 2001-10-10
BR9916434A (pt) 2001-09-04
AU1570200A (en) 2000-07-12

Similar Documents

Publication Publication Date Title
MY131890A (en) Piperidine compounds
ATE431738T1 (de) Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
DK1041987T3 (da) Oral farmaceutisk doseringsform omfattende en kombination af en opioid-agonist og naltrexon
ATE450508T1 (de) Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren
CA2424664A1 (en) Novel non-imidazole compounds
EE05171B1 (et) Peroraalne ravimvorm, mis sisaldab opioidagonisti vabanevas vormis ja eraldatud opioidantagonisti, meetod selle valmistamiseks ning selle kasutamine meditsiinis
EE04178B1 (et) 3- või 4-asendatud 4-(aminometüül)piperidiini bitsüklilised bensamiidid, vaheühend ja farmatseutiline kompositsioon ning nende valmistamismeetodid
PL398391A1 (pl) Koniugat hydroksyalkiloskrobi i polipeptydu, sposób wytwarzania tego koniugatu, jego zastosowanie oraz kompozycja farmaceutyczna zawierająca koniugat hydroksyalkiloskrobi i polipeptydu
HUP9800938A2 (hu) NK-1 receptor antagonisták alkalmazása irritációs bélszindróma tüneteinek kezelésére
ID26223A (id) Antagonis reseptor vitronektin
IS2356B (is) Notkun á sértæku mótlyfi fyrir 5HT2 viðtaka til framleiðslu á læknislyfjum sem eru nytsamleg við meðhöndlun á svefn-truflaðri öndun
HUP0300599A3 (en) Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
NO20013118D0 (no) Anvendelse av en 5HT2A og 5HT2A/C reseptor-antagonist for fremstilling av medisiner for behandling av snorking og syndrommed höy motstand i övre anatomiske luftveier
ATE279923T1 (de) Urotensin-ii rezeptorantagonisten
WO2000025766A3 (en) Use of nk antagonist for treating gastric asthma
NO20041595L (no) Ny kombinasjon bestaende av en PDE4 inhibitor eller en PDE3/4 inhibitor i kombinasjon med en leukotrienreseptorantagonist for behandling av luftveislidelser
HUP0300470A3 (en) Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
WO2002069944A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und nk1-rezeptor-antagonisten
TWI256388B (en) Pharmaceutical combination
BR9914397A (pt) Derivados da ureidopiperidina como antagonistas seletivos dos receptores nk3 humanos
IS8388A (is) Blandan af serótónín endurupptökuhindra og histamín 3 viðtaka mótlyfi, öflugum verka eða hlutaverka
ZA9810469B (en) Use of a specific 5ht2 receptor antagonist for the preparation of medicines useful in the treatment of the sleep apnea syndrome
HUP0300305A3 (en) Il-8 receptor antagonists, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application